soft

DRUG3 trials

Sponsors

Curateq Biologics Private Limited, Umecrine Cognition AB, Skane University Hospital

Conditions

OverweightPost-Menopausal OsteoporosisPrimary biliary cholangitis (PBC)

Phase 1

A randomised, double-blind, placebo-controlled, two-part study to evaluate the pharmacokinetics, safety and tolerability, and preliminary efficacy of two dose levels of golexanolone in subjects with primary biliary cholangitis, fatigue, and cognitive dysfunction.

RecruitingCTIS2024-515907-20-00

Umecrine Cognition ABPrimary biliary cholangitis (PBC)

Start: 2025-05-23Target: 116Updated: 2026-01-16

Phase 3

A Phase III, Randomized, Double-Blind, Parallel Group, Multicenter Study to Compare Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of BP16 Versus EU-Prolia® in Women with Post- Menopausal Osteoporosis

CompletedCTIS2023-503790-37-00

Curateq Biologics Private LimitedPost-Menopausal Osteoporosis

Start: 2024-01-09End: 2025-12-11Target: 615Updated: 2025-11-05

Unknown Phase

Treatment of Overweight in Children on Distance

Active, not recruitingNCT02720302

Skane University HospitalOverweight

Start: 2016-03-01End: 2027-01-31Updated: 2026-05-04